Enzyme Replacement Therapy Market Share, Size, and Trends by 2028
Enzyme Replacement Therapy Market: Strategic Insights
Enzyme Replacement Therapy Market
-
CAGR (2021 - 2028)6.8% -
Market Size 2021
US$ 9.67 Billion -
Market Size 2028
US$ 15.18 Billion
Market Dynamics
GROWTH DRIVERS
- Increasing prevalence of lysosomal storage disorders (LSDs)
- Advancements in recombinant DNA technology
- Rising healthcare expenditure
- Growing geriatric population
- Launch of novel therapies
- Favorable reimbursement scenarios
- Increasing awareness about LSDs and their treatment options
FUTURE TRENDS
- Advancement in gene therapy and CRISPR-Cas9 technology
- Development of combination therapies
- Increased focus on patient-centric care
- Rising demand for biosimilars and generic enzyme replacement therapies
- Growing importance of real-world evidence and patient registries
OPPORTUNITIES
- Increasing pipeline of novel enzyme replacement therapies
- Expanding geographic reach
- Strategic collaborations and partnerships
- Rising demand for personalized medicine
- Growing focus on orphan diseases
Key Players
- Sanofi
- BioMarin Pharmaceutical Inc
- Takeda Pharmaceutical Company Limited
- AbbVie Inc
- Janssen Pharmaceuticals Johnson Johnson Services Inc
- Alexion Pharmaceuticals Inc AstraZeneca
- Amicus Therapeutics
- Recordati S p A
- CHIESI Farmaceutici S p A
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Enzyme Type - Alglucosidase Alfa
- Agalsidase Beta
- Imiglucerase
- Idursulfase
- Galsulfase
- Velaglucerase Alfa
- Other Enzymes
Therapeutic Conditions - Gaucher's Disease
- Fabry's Disease
- MPS
- Pompe's Disease
- SCID
- Other Therapeutic Conditions
Route of Administration - Parenteral and Oral
End User - Hospitals
- Infusion Centers
Get Free Sample For